Werewolf Therapeutics to Present Clinical and Preclinical Data at …
https://investors.werewolftx.com/news-releases/news-release-details/werewolf-therapeutics-present-clinical-and-preclinical-data
WEBWATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that a poster …
DA: 53 PA: 13 MOZ Rank: 54